AGP Picks
View all

Syria Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Syria Technology Digest.

Press releases published on October 21, 2026

Santa Ana Bio to Present Preclinical Data on SAB05, a CD40-Targeted Glucocorticoid Antibody-Drug Conjugate, at ACR Convergence 2026
Inspire and PatientPartner Announce Partnership to Expand Patient Mentorship and Community Support
Constellation Software Inc. Announces Appointment of Daan Dijkhuizen as Chief AI Officer
Delinea Fastpath Launches MCP Server for AI-Powered Access Governance and Audit Readiness
Veeco Announces Date for Third Quarter 2026 Financial Results and Conference Call
Voyager Announces CEO Succession Plan, Appoints Robin Swartz President
Quantum X Labs’ Decoder Delivers Lowest Logical Error Rates by integrating NVIDIA CUDA-Q QEC in Comparison to Other Decoders
Dr. Falk Pharma and Renexxion Reach Alignment with FDA and EMA on Phase 3 Program for Naronapride in Gastroparesis
TechnoMile Recognized as a 2026 Inc. Power Partner Award Winner
PolyPid to Present D-PLEX₁₀₀ Microbiology Data at IDWeek 2026
Kora Studio 1.0 makes every junior architect design like a Revit expert
Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026
red violet to Announce Third Quarter 2026 Financial Results on November 4, 2026
isolved Places AI Agents on the Org Chart Alongside People, Advancing Workforce Capital Management
HiBob Named Core Leader in 2026 Fosway 9-Grid™ for Cloud HR as European HCM Market Raises the Bar
Collegium to Present Pediatric and Real-World Research Across ADHD Portfolio at AACAP and NEI Fall Congresses
Rhythm Pharmaceuticals to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026
Amarin to Report Third Quarter 2026 Financial Results and Host Conference Call on October 28, 2026
Sutro Biopharma Announces First Patient Dosed in Phase 1 Trial of STRO-006, a Next-Generation ITGB6-Targeting ADC, in Advanced Solid Tumors
Arbor Biotechnologies Nominates Three Gene Editing Development Candidates for ALS, with Potential to Address Up to 97% of People Living with the Disease

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Syria Technology Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.